{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:22:24Z","timestamp":1791350544575,"version":"4.3.1"},"reference-count":137,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The modern combined antiretroviral treatment (cART) for human immunodeficiency virus (HIV) infection has substantially lowered the incidence of HIV-associated dementia (HAD). The dominant clinical features include deficits in cognitive processing speed, concentration, attention, and memory. As people living with HIV become older, with high rates of comorbidities and concomitant treatments, the prevalence and complexity of cognitive impairment are expected to increase. Currently, the management of HAD and milder forms of HAND is grounded on the best clinical practice, as there is no specific, evidence-based, proven intervention for managing cognitive impairment. The present article acknowledges the multifactorial nature of the cognitive impairments found in HIV patients, outlining the current concepts in the field of HAD. Major areas of interest include neuropsychological testing and neuroimaging to evaluate CNS status, focusing on greater reliability in the exclusion of associated diseases and allowing for earlier diagnosis. Additionally, we considered the evidence for neurological involvement in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the impact of the coronavirus (COVID-19) pandemic, with wider consequences to population health than can be attributed to the virus itself. The indirect effects of COVID-19, including the increased adoption of telehealth, decreased access to community resources, and social isolation, represent a significant health burden, disproportionately affecting older adults with dementia who have limited social networks and increased functional dependence on the community and health system. This synopsis reviews these aspects in greater detail, identifying key gaps and opportunities for researchers and clinicians; we provide an overview of the current concepts in the field of HAD, with suggestions for diagnosing and managing this important neurological complication, which is intended to be applicable across diverse populations, in line with clinical observations, and closely representative of HIV brain pathology.<\/jats:p>","DOI":"10.3390\/v15020378","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T07:34:41Z","timestamp":1675064081000},"page":"378","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Assessment and Diagnosis of HIV-Associated Dementia"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7293-3414","authenticated-orcid":false,"given":"Amalia","family":"Cornea","sequence":"first","affiliation":[{"name":"Department of Neurology, Victor Babes University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania"},{"name":"Department of Neurology, Clinical Emergency County Hospital Timisoara, Bd. Iosif Bulbuca No. 10, 300736 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Lata","sequence":"additional","affiliation":[{"name":"Department of Neurology, Clinical Emergency County Hospital Timisoara, Bd. Iosif Bulbuca No. 10, 300736 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9676-1282","authenticated-orcid":false,"given":"Mihaela","family":"Simu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Victor Babes University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania"},{"name":"Department of Neurology, Clinical Emergency County Hospital Timisoara, Bd. Iosif Bulbuca No. 10, 300736 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2412-1942","authenticated-orcid":false,"given":"Elena Cecilia","family":"Rosca","sequence":"additional","affiliation":[{"name":"Department of Neurology, Victor Babes University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania"},{"name":"Department of Neurology, Clinical Emergency County Hospital Timisoara, Bd. Iosif Bulbuca No. 10, 300736 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022, November 15). Summary of the Global HIV Epidemic. Available online: https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1212\/WNL.0000000000010752","article-title":"Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis","volume":"95","author":"Wang","year":"2020","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"581346","DOI":"10.3389\/fneur.2020.581346","article-title":"The Prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-Infected Adults: A Systematic Review and Meta-Analysis","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.2147\/IJGM.S295859","article-title":"HIV-Associated Neurocognitive Disorder (HAND): Obstacles to Early Neuropsychological Diagnosis","volume":"15","author":"Vastag","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410190602","article-title":"The AIDS dementia complex: I. Clinical features","volume":"19","author":"Navia","year":"1986","journal-title":"Ann. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/0003-4819-107-6-828","article-title":"Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging","volume":"107","author":"Grant","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"ref_7","unstructured":"World Health Organization (2023, January 26). Report of the Second Consultation on the Neuropsychiatric Aspects of HIV Infection, Geneva, 11\u201313 January 1990. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/61603."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"(1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology, 41, 778\u2013785.","DOI":"10.1212\/WNL.41.6.778"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/cid\/ciab366","article-title":"Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living with Human Immunodeficiency Virus and a Proposed Way Forward","volume":"73","author":"Nightingale","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gissl\u00e9n, M., Price, R.W., and Nilsson, S. (2011). The definition of HIV-associated neurocognitive disorders: Are we overestimating the real prevalence?. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-356"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s15010-019-01373-8","article-title":"Considerations on nosology for HIV-associated neurocognitive disorders: It is time to update?","volume":"48","author":"Ciccarelli","year":"2020","journal-title":"Infection"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","article-title":"Controversies in HIV-associated neurocognitive disorders","volume":"13","author":"Nightingale","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","article-title":"Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline","volume":"82","author":"Grant","year":"2014","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia","volume":"24","author":"Simioni","year":"2010","journal-title":"Aids"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.qai.0000197077.64021.07","article-title":"Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy","volume":"41","author":"Giancola","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","article-title":"Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort","volume":"25","author":"Smurzynski","year":"2011","journal-title":"Aids"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11065-009-9095-0","article-title":"Functional consequences of HIV-associated neuropsychological impairment","volume":"19","author":"Gorman","year":"2009","journal-title":"Neuropsychol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cysique, L.A., Waters, E.K., and Brew, B.J. (2011). Central nervous system antiretroviral efficacy in HIV infection: A qualitative and quantitative review and implications for future research. BMC Neurol., 11.","DOI":"10.1186\/1471-2377-11-148"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1128\/JVI.78.18.10133-10148.2004","article-title":"Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment","volume":"78","author":"Smit","year":"2004","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","article-title":"Antiretroviral neurotoxicity","volume":"18","author":"Robertson","year":"2012","journal-title":"J. Neurovirol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/1980-57642015DN94000380","article-title":"Neuroimaging of HIV-associated neurocognitive disorders","volume":"9","author":"Haziot","year":"2015","journal-title":"Dement. Neuropsychol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11904-014-0221-0","article-title":"HIV associated neurocognitive disorders in the modern antiviral treatment era: Prevalence, characteristics, biomarkers, and effects of treatment","volume":"11","author":"Chan","year":"2014","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.410140404","article-title":"Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients","volume":"14","author":"Snider","year":"1983","journal-title":"Ann. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","article-title":"HIV-associated neurocognitive disorder","volume":"13","author":"Clifford","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J. Neurovirol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1212\/WNL.52.1.109","article-title":"Paroxysmal dyskinesias in patients with HIV infection","volume":"52","author":"Mirsattari","year":"1999","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2004.03.001","article-title":"Movement disorders and AIDS: A review","volume":"10","author":"Tse","year":"2004","journal-title":"Park. Relat. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/13550280802216494","article-title":"Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy","volume":"14","author":"Valcour","year":"2008","journal-title":"J. Neurovirol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","article-title":"Cognitive neuropsychology of HIV-associated neurocognitive disorders","volume":"19","author":"Woods","year":"2009","journal-title":"Neuropsychol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1076\/jcen.21.5.730.867","article-title":"Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report","volume":"21","author":"Martin","year":"1999","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/jnnp.58.4.399","article-title":"Neuropsychiatric aspects of HIV infection","volume":"58","author":"Everall","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"J. Neurovirol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QAD.0b013e3283437f9a","article-title":"HIV-1 infection and cognitive impairment in the cART era: A review","volume":"25","author":"Schouten","year":"2011","journal-title":"Aids"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1076\/jcen.24.7.912.8391","article-title":"Reaction time performance in adults with HIV\/AIDS","volume":"24","author":"Hardy","year":"2002","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/13854040490501448","article-title":"Initial validation of a screening battery for the detection of HIV-associated cognitive impairment","volume":"18","author":"Carey","year":"2004","journal-title":"Clin. Neuropsychol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1017\/S1355617702813212","article-title":"A meta-analysis of the neuropsychological sequelae of HIV infection","volume":"8","author":"Reger","year":"2002","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/13803390701565225","article-title":"Variable patterns of neuropsychological performance in HIV-1 infection","volume":"30","author":"Dawes","year":"2008","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S1355617704102130","article-title":"The impact of HIV-associated neuropsychological impairment on everyday functioning","volume":"10","author":"Heaton","year":"2004","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11904-016-0324-x","article-title":"Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals","volume":"13","author":"Underwood","year":"2016","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_41","unstructured":"EACS (2022, November 08). European AIDS Clinical Society Guidelines. Available online: https:\/\/www.eacsociety.org\/media\/guidelines-11.1_final_09-10.pdf."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/cis975","article-title":"Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program","volume":"56","author":"Antinori","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","unstructured":"(2022, November 08). New Italian Guidelines on the Use of Antiretroviral Therapy and the Clinical-Diagnostic Management of HIV-1 Affected Patients. Available online: https:\/\/penta-id.org\/news\/new-italian-guidelines-on-the-use-of-antiretroviral-therapy-and-the-clinical-diagnostic-management-of-hiv-1-affected-patients\/."},{"key":"ref_44","unstructured":"British HIV Association (2023, January 26). BHIVA Guidelines for the Routine Investigation and Monitoring of Adult HIV-1-Positive Individuals 2016 (2019 Interim Update). Available online: https:\/\/www.bhiva.org\/monitoring-guidelines."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e3572","DOI":"10.1093\/cid\/ciaa1391","article-title":"Primary Care Guidance for Persons with Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"73","author":"Thompson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","unstructured":"World Health Organization (2023, January 26). Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241511124."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11904-013-0176-6","article-title":"Validity of cognitive screens for HIV-associated neurocognitive disorder: A systematic review and an informed screen selection guide","volume":"10","author":"Kamminga","year":"2013","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/7854_2019_117","article-title":"Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity","volume":"50","author":"Robbins","year":"2021","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11065-019-09412-9","article-title":"Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders","volume":"29","author":"Rosca","year":"2019","journal-title":"Neuropsychol. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rosca, E.C., Tadger, P., Cornea, A., Tudor, R., Oancea, C., and Simu, M. (2021). International HIV Dementia Scale for HIV-Associated Neurocognitive Disorders: A Systematic Review and Meta-Analysis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11061124"},{"key":"ref_51","first-page":"1367","article-title":"The International HIV Dementia Scale: A new rapid screening test for HIV dementia","volume":"19","author":"Sacktor","year":"2005","journal-title":"Aids"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2006.03.023","article-title":"The HIV Dementia Scale: Predictive power in mild dementia and HAART","volume":"260","author":"Bottiggi","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-1293.2008.00679.x","article-title":"Neurocognitive screening tools in HIV\/AIDS: Comparative performance among patients exposed to antiretroviral therapy","volume":"10","author":"Skinner","year":"2009","journal-title":"HIV Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Haddow, L.J., Floyd, S., Copas, A., and Gilson, R.J. (2013). A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061826"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/QAD.0b013e328363bf56","article-title":"Evaluation of brief screening tools for neurocognitive impairment in HIV\/AIDS: A systematic review of the literature","volume":"27","author":"Zipursky","year":"2013","journal-title":"Aids"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kami-Onaga, K., Tateyama, M., Kinjo, T., Parrott, G., Tominaga, D., Takahashi-Nakazato, A., Nakamura, H., Tasato, D., Miyagi, K., and Maeda, S. (2018). Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199106"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/13854046.2016.1183048","article-title":"Neuropsychological screening tools in Italian HIV+ patients: A comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE)","volume":"30","author":"Milanini","year":"2016","journal-title":"Clin. Neuropsychol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WAD.0b013e3182420bfe","article-title":"Montreal cognitive assessment: Validation study for mild cognitive impairment and Alzheimer disease","volume":"27","author":"Freitas","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","article-title":"Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease","volume":"73","author":"Hoops","year":"2009","journal-title":"Neurology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1017\/S1092852920001868","article-title":"Montreal cognitive assessment for evaluating cognitive impairment in Huntington\u2019s disease: A systematic review","volume":"27","author":"Rosca","year":"2020","journal-title":"CNS Spectr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s13760-020-01509-w","article-title":"Montreal cognitive assessment for evaluating cognitive impairment in multiple sclerosis: A systematic review","volume":"120","author":"Rosca","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.genhosppsych.2020.05.011","article-title":"Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review","volume":"65","author":"Rosca","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/gps.4756","article-title":"A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores","volume":"33","author":"Carson","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_65","first-page":"134","article-title":"Validity of two scales in identifying HIV-associated dementia","volume":"21","author":"Berghuis","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.acn.2005.07.011","article-title":"The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery","volume":"21","author":"Cysique","year":"2006","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2196\/mhealth.9148","article-title":"A Mobile App to Screen for Neurocognitive Impairment: Preliminary Validation of NeuroScreen Among HIV-Infected South African Adults","volume":"6","author":"Robbins","year":"2018","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7309\/jmtm.3.1.5","article-title":"A Smartphone App to Screen for HIV-Related Neurocognitive Impairment","volume":"3","author":"Robbins","year":"2014","journal-title":"J. Mob. Technol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciw399","article-title":"A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review","volume":"63","author":"Bloch","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/arclin\/acac045","article-title":"Preliminary Findings from a Telephone-Based Cognitive Screening of an Adult HIV Research Cohort during the COVID-19 Pandemic","volume":"37","author":"Gonzalez","year":"2022","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_71","first-page":"Cd013786","article-title":"Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment","volume":"7","author":"McCleery","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/QAD.0000000000002144","article-title":"Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: Youth-International HIV Dementia Scale validation","volume":"33","author":"Phillips","year":"2019","journal-title":"Aids"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13854046.2012.759627","article-title":"Exploring the utility of the Montreal Cognitive Assessment to detect HIV-associated neurocognitive disorder: The challenge and need for culturally valid screening tests in South Africa","volume":"27","author":"Robbins","year":"2013","journal-title":"Clin. Neuropsychol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S135561771100141X","article-title":"Diagnosing symptomatic HIV-associated neurocognitive disorders: Self-report versus performance-based assessment of everyday functioning","volume":"18","author":"Blackstone","year":"2012","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/ADM.0b013e318293653d","article-title":"Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use","volume":"7","author":"Blackstone","year":"2013","journal-title":"J. Addict. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13365-019-00809-z","article-title":"Operationalizing and evaluating the Frascati criteria for functional decline in diagnosing HIV-associated neurocognitive disorders in adults","volume":"26","author":"Matchanova","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000354629","article-title":"Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power","volume":"41","author":"Meyer","year":"2013","journal-title":"Neuroepidemiology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-1293.2012.01044.x","article-title":"Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients","volume":"14","author":"Fabbiani","year":"2013","journal-title":"HIV Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.0b013e3181f11bd8","article-title":"Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons","volume":"75","author":"Wright","year":"2010","journal-title":"Neurology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1212\/WNL.0b013e3181bd10e7","article-title":"Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men","volume":"73","author":"Becker","year":"2009","journal-title":"Neurology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s13365-012-0092-3","article-title":"Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy","volume":"18","author":"Cruse","year":"2012","journal-title":"J. Neurovirol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/bmb\/ldy019","article-title":"Cognitive Impairment in people living with HIV in the ART era: A Review","volume":"127","author":"Alford","year":"2018","journal-title":"Br. Med. Bull."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Sangarlangkarn, A., Yamada, Y., and Ko, F.C. (2021). HIV and Aging: Overcoming Challenges in Existing HIV Guidelines to Provide Patient-Centered Care for Older People with HIV. Pathogens, 10.","DOI":"10.3390\/pathogens10101332"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s13365-015-0366-7","article-title":"Elevated rates of mild cognitive impairment in HIV disease","volume":"21","author":"Sheppard","year":"2015","journal-title":"J. Neurovirol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s13365-019-00735-0","article-title":"Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders","volume":"25","author":"Rosenthal","year":"2019","journal-title":"J. Neurovirol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QAI.0000000000001091","article-title":"ApoE \u03b54 Is Associated With Cognition, Brain Integrity, and Atrophy in HIV Over Age 60","volume":"73","author":"Wendelken","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1212\/WNL.0000000000000526","article-title":"Effects of APOE \u03b54, age, and HIV on glial metabolites and cognitive deficits","volume":"82","author":"Chang","year":"2014","journal-title":"Neurology"},{"key":"ref_89","first-page":"1","article-title":"An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition","volume":"4","author":"Turner","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1078390314527549","article-title":"An overview of the biological and psychosocial context surrounding neurocognition in HIV","volume":"20","author":"Vance","year":"2014","journal-title":"J Am Psychiatr. Nurses Assoc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00007435-199708000-00003","article-title":"Neurocognitive impairment in human immunodeficiency virus infection is correlated with sexually transmitted disease history","volume":"24","author":"Wallace","year":"1997","journal-title":"Sex. Transm. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12603-020-1389-1","article-title":"Clinical Presentation of COVID19 in Dementia Patients","volume":"24","author":"Bianchetti","year":"2020","journal-title":"J. Nutr. Health Aging"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Ge, E., Li, Y., Wu, S., Candido, E., and Wei, X. (2021). Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0258154"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jamaneurol.2021.5330","article-title":"Addressing Vulnerability and Dementia in the Era of COVID-19","volume":"79","author":"Guterman","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamaneurol.2022.0010","article-title":"Trends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic","volume":"79","author":"Gilstrap","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s13365-020-00897-2","article-title":"Studying the neuropsychological sequelae of SARS-CoV-2: Lessons learned from 35 years of neuroHIV research","volume":"26","author":"Levine","year":"2020","journal-title":"J. Neurovirol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/wps.20837","article-title":"The emergence of cognitive COVID","volume":"20","author":"Ritchie","year":"2021","journal-title":"World Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/02699050500488199","article-title":"Brain atrophy and cognitive impairment in survivors of Acute Respiratory Distress Syndrome","volume":"20","author":"Hopkins","year":"2006","journal-title":"Brain Inj."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"103795","DOI":"10.1016\/j.msard.2022.103795","article-title":"Autoimmune encephalitis associated with COVID-19: A systematic review","volume":"62","author":"Nabizadeh","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1017\/S0033291704002247","article-title":"Severe acute respiratory syndrome (SARS) in Hong Kong in 2003: Stress and psychological impact among frontline healthcare workers","volume":"34","author":"Tam","year":"2004","journal-title":"Psychol. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ajic.2016.03.014","article-title":"Middle East respiratory syndrome in South Korea during 2015: Risk-related perceptions and quarantine attitudes","volume":"44","author":"Kim","year":"2016","journal-title":"Am. J. Infect. Control"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbi.2012.06.012","article-title":"Effects of the common cold on mood, psychomotor performance, the encoding of new information, speed of working memory and semantic processing","volume":"26","author":"Smith","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"ref_105","first-page":"35","article-title":"Cognitive impairment in patients with AIDS\u2014Prevalence and severity","volume":"7","author":"Watkins","year":"2015","journal-title":"HIV AIDS"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/NBHIV.S30466","article-title":"Management issues in HIV-associated neurocognitive disorders","volume":"4","author":"Cysique","year":"2012","journal-title":"Neurobehav. HIV Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11904-019-00421-0","article-title":"HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy","volume":"16","author":"Rubin","year":"2019","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s10461-018-2051-3","article-title":"Prevalence, Comorbidity, and Correlates of Psychiatric and Substance Use Disorders and Associations with HIV Risk Behaviors in a Multisite Cohort of Women Living with HIV","volume":"22","author":"Cook","year":"2018","journal-title":"AIDS Behav."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2017.0202","article-title":"Neuropsychological Assessment of 412 HIV-Infected Individuals in S\u00e3o Paulo, Brazil","volume":"32","author":"Vidal","year":"2018","journal-title":"AIDS Patient Care STDS"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s13365-013-0195-5","article-title":"A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder","volume":"19","author":"Rosenthal","year":"2013","journal-title":"J. Neurovirol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11481-019-09886-7","article-title":"CNS Neurotoxicity of Antiretrovirals","volume":"16","author":"Lanman","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s40264-016-0440-y","article-title":"Neuropsychiatric Effects of HIV Antiviral Medications","volume":"39","author":"Treisman","year":"2016","journal-title":"Drug Saf."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/jac\/dkv183","article-title":"Efavirenz and the CNS: What we already know and questions that need to be answered","volume":"70","author":"Apostolova","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11481-019-09868-9","article-title":"Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury","volume":"16","author":"Yuan","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11481-015-9634-9","article-title":"Effect of HAART on Brain Organization and Function in HIV-Negative Subjects","volume":"10","author":"Brier","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"108047","DOI":"10.1016\/j.pharmthera.2021.108047","article-title":"HIV-associated neurotoxicity and cognitive decline: Therapeutic implications","volume":"234","author":"Wallace","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: Epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J. Neurol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/517379","article-title":"High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis","volume":"177","author":"Morris","year":"1998","journal-title":"J. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","article-title":"CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease","volume":"73","author":"Clifford","year":"2009","journal-title":"Neurology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ene.12006","article-title":"Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration","volume":"20","author":"Steinbrink","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Ed\u00e9n, A., Marcotte, T.D., Heaton, R.K., Nilsson, S., Zetterberg, H., Fuchs, D., Franklin, D., Price, R.W., Grant, I., and Letendre, S.L. (2016). Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157160"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1212\/01.WNL.0000031811.45569.B0","article-title":"Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients","volume":"59","author":"Ernst","year":"2002","journal-title":"Neurology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jmri.10295","article-title":"A multi-center 1H MRS study of the AIDS dementia complex: Validation and preliminary analysis","volume":"17","author":"Lee","year":"2003","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.neuroimage.2004.07.067","article-title":"A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age","volume":"23","author":"Chang","year":"2004","journal-title":"Neuroimage"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-444-63849-6.00018-9","article-title":"Imaging studies of the HIV-infected brain","volume":"152","author":"Chang","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2004.08.036","article-title":"Neuroimaging in human immunodeficiency virus infection","volume":"157","author":"Tucker","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00126334-200108010-00003","article-title":"Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz","volume":"27","author":"Blanch","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.clinph.2017.03.035","article-title":"The electrophysiology of neuroHIV: A systematic review of EEG and MEG studies in people with HIV infection since the advent of highly-active antiretroviral therapy","volume":"128","author":"Fellows","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcv.2008.07.003","article-title":"False negative PCR despite high levels of JC virus DNA in spinal fluid: Implications for diagnostic testing","volume":"43","author":"Landry","year":"2008","journal-title":"J. Clin. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/ajns.AJNS_243_17","article-title":"Progressive Multifocal Leukoencephalopathy Diagnosed by Brain Biopsy, not by the DNA Test for JC Virus","volume":"14","author":"Lee","year":"2019","journal-title":"Asian J. Neurosurg."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/clinids\/22.6.906","article-title":"Neuroimaging findings in patients with AIDS","volume":"22","author":"Walot","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1016\/S2352-3018(20)30107-7","article-title":"Cognitive disorders in people living with HIV","volume":"7","author":"Winston","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/13550280009006385","article-title":"Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors","volume":"6","author":"Sacktor","year":"2000","journal-title":"J. Neurovirol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_136","first-page":"137","article-title":"Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder","volume":"19","author":"Letendre","year":"2011","journal-title":"Top. Antivir. Med."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Arentoft, A., Troxell, K., Alvarez, K., Aghvinian, M., Rivera Mindt, M., Cherner, M., Van Dyk, K., Razani, J., Roxas, M., and Gavilanes, M. (2022). HIV Antiretroviral Medication Neuropenetrance and Neurocognitive Outcomes in HIV+ Adults: A Review of the Literature Examining the Central Nervous System Penetration Effectiveness Score. Viruses, 14.","DOI":"10.3390\/v14061151"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/378\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:17:59Z","timestamp":1760120279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/2\/378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":137,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["v15020378"],"URL":"https:\/\/doi.org\/10.3390\/v15020378","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]}}}